Lilly, Medical Centers Agree To Settle Diet Drugs Trademark Case In Federal Court
SEATTLE — Eli Lilly and Co., two medical centers and two of their physicians who prescribe patients compounded versions of tirzepatide, a Food and Drug Administration-approved drug for diabetes and weight...To view the full article, register now.
Already a subscriber? Click here to view full article